COGT
Cogent Biosciences, Inc.Company with tickers: COGT
CIK
1622229
CUSIP
19240Q201
Shares Outstanding
170,868,004
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $63,029,000 | USD | 2025-03-31 | 10-Q | 2026-05-05 |
| Operating Income | $-74,933,000 | USD | 2025-03-31 | 10-Q | 2026-05-05 |
| Net Income | $-71,986,000 | USD | 2025-03-31 | 10-Q | 2026-05-05 |
| EPS (Basic) | $-0.52 | USD/shares | 2025-03-31 | 10-Q | 2026-05-05 |
| EPS (Diluted) | $-0.52 | USD/shares | 2025-03-31 | 10-Q | 2026-05-05 |